Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

355

Actual shortage: 107 (30%)
Anticipated shortage: 1 (0%)
Avoided shortage: 0 (0%)
Resolved: 247 (70%)

Discontinuation Reports

110

To be discontinued: 0 (0%)
Discontinued: 110 (100%)
Reversed: 0 (0%)

Late reports

146 (31%)

Overdue reports

0 (0%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT AMLODIPINE 2.5MG TABLET Resolved 2017-03-17 2017-09-19 3348
ACT AMPHETAMINE XR 3.75MG 3.75MG 3.75MG 3.75MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60068
ACT AMPHETAMINE XR 5MG 5MG 5MG 5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60075
ACT AMPHETAMINE XR 6.25MG 6.25MG 6.25MG 6.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61330
ACT AMPHETAMINE XR 7.5MG 7.5MG 7.5MG 7.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61333
ACT AMPHETAMINE XR 1.25MG 1.25MG 1.25MG 1.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61336
ACT AMPHETAMINE XR 2.5MG 2.5MG 2.5MG 2.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-11-30 2019-01-31 68265
ACT CIPROFLOXACIN 750MG TABLET Resolved 2018-09-12 2018-10-11 61365
ACT CIPROFLOXACIN 500MG TABLET Resolved 2018-12-04 2019-03-12 68599
ACT DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Resolved 2017-05-10 2017-09-19 9901
ACT DILTIAZEM CD 300MG CAPSULE (EXTENDED RELEASE) Actual shortage 2018-09-12 2018-10-11 61340
ACT DILTIAZEM CD Actual shortage 2018-12-04 2018-12-04 68602
ACT ENALAPRIL 4MG TABLET Resolved 2017-08-24 2017-10-10 20315
ACT ENALAPRIL 16MG TABLET Resolved 2017-08-24 2017-10-10 20326
ACT ENALAPRIL 8MG TABLET Resolved 2018-09-12 2019-03-12 61343
ACT ENALAPRIL 2MG TABLET Resolved 2018-09-12 2019-01-31 61346
ACT ENALAPRIL 16MG TABLET Actual shortage 2018-09-12 2019-03-12 61349
ACT ENALAPRIL 4MG TABLET Resolved 2018-09-12 2019-01-31 61352
ACT ESOMEPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2017-05-10 2018-07-30 9912
ACT LEVOFLOXACIN 500MG TABLET Actual shortage 2018-06-15 2019-04-11 52485

Showing 1 to 20 of 355

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
GEMCITABINE FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14033
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Discontinued 2017-06-27 2017-06-27 14036
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVAMOXIN 25MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81393
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63955
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63959
NOVASEN 650MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63964
NOVO-PROFEN 400MG TABLET Discontinued 2018-10-19 2018-10-19 64920
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615

Showing 21 to 40 of 110